Patents by Inventor Antje Ritter

Antje Ritter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cystobactamide derivatives
    Patent number: 11034648
    Abstract: The present invention relates to novel derivatives of cystobactamides of formula (Ib) and the use thereof for the treatment or prophylaxis of bacterial infections.
    Type: Grant
    Filed: August 23, 2018
    Date of Patent: June 15, 2021
    Assignees: HELMHOLTZ-ZENTRUM FÜR, INFEKTIONSFORSCHUNG GMBH
    Inventors: Giambattista Testolin, Mark Brönstrup, Hans-Peter Prochnow, Jennifer Herrmann, Rolf Müller, Charlotte Grandclaudon, Tim Mollner, Antje Ritter
  • NOVEL CYSTOBACTAMIDE DERIVATIVES
    Publication number: 20200190020
    Abstract: The present invention relates to novel derivatives of cystobactamides of formula (Ib) and the use thereof for the treatment or prophylaxis of bacterial infections.
    Type: Application
    Filed: August 23, 2018
    Publication date: June 18, 2020
    Inventors: Giambattista Testolin, Mark Brönstrup, Hans-Peter Prochnow, Jennifer Herrmann, Rolf Müller, Charlotte Grandclaudon, Tim Mollner, Antje Ritter
  • Novel Ubiquitin-Isopeptide Probes
    Publication number: 20120184482
    Abstract: The invention relates to a ubiquitin-isopeptide probe (hereinafter also referred to as UIPP), a method for its preparation, and its use. The invention also provides a method for isolating a deubiquitinating enzyme and a method for activity-based protein profiling (ABPP).
    Type: Application
    Filed: August 19, 2011
    Publication date: July 19, 2012
    Applicant: Helmholtz-Zentrum fuer Infektionsforschung GmbH
    Inventors: Alexander Iphoefer, Raimo Franke, Antje Ritter, Tatjana Arnold, Lothar Jaensch